(ATDN) Thalidomide and Anti-TNF Mab

(ATDN) Thalidomide and Anti-TNF Mab

Treatment Review #18; April 1995

This study will compare IL-2 alone to Il-2 in combination with an anti-TNF monoclonal antibody to Il-2 in combination with thalidomide for the treatment of HIV infection in people with 200-500 T4 cells. All participants will receive IL-2 by continuous IV infusion for 5 days approximately every 8 weeks. One group will also take anti-TNF monoclonal antibody. The second group will also take thalidomide. The third group will take only IL-2. To participate you must have been on current treatment with a stable regimen of an approved antiretroviral therapy for at least two weeks. Treatment is for one year.

950401
ATR01807

Always watch for outdated information. This article first appeard in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

Copyright © 1995 - AIDS Treatment Data Network. If you want to copy, reproduce or excerpt this information, please give us a call at (800) 734-7104. This helps up to keep track of where and how this information is being used. You can also Email us at network@atdn.org http://206.179.124.69/network/index.html

This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1995. AEGIS.